IRCT20231116060079N1 IRCT 2023-12-30 Tabriz University of Medical Sciences Investigating the effect of nandrolone on the quality of life Investigating the effect of nandrolone on the quality of life in female patients with heart failure 2024-01-21 anticipated 90 Complete https://irct.ir/trial/74583 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Other, Randomization description: Patients will be randomly with Block randomization assigned to one of the intervention or placebo groups using computer-generated numbers produced by the Random allocation software. Thus, in this software, the number of groups and the total sample size will be entered, and then the "randomization” will be implemented in the block section. Then, the computer-generated number list will be given to the physician, and the physician will assign patients to groups according to the determined order by the software for entry into one of the groups. Thus, the randomization process will continue until the final sample size is reached, Blinding description: The study will be conducted as a single-blind clinical trial. The patient will be blind about her allocation to the intervention or placebo group. The Syringes of drug and placebo will be similar in shape, size and color. 3 Heart failure. Intervention 1: Intervention group: Patients in the intervention group will receive nandrolone decanoate 25 mg intramuscularly once a week for one month that will be provided by Caspian Pharmaceutical Company. Intervention 2: Control group: Patients in the placebo group will receive 25 mg vials of isotonic solution will be provided by Caspian Pharmaceutical Company. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information